Cosmo Pharmaceuticals NV is an Ireland-based pharmaceutical company specializing in gastrointestinal diseases, dermatology, and healthtech solutions. With a medium risk rating score of 29.4, Cosmo Pharmaceuticals NV is known for developing and manufacturing products such as Lialda/Mezavant/Mesavancol, Uceris/Cortiment, GI Genius, Eleview, Aemcolo, and Winlevi, distributed globally through partnerships. Their product pipeline includes innovative solutions like Breezula, Methylene blue MMX, and CB-01-33. Explore Cosmo Pharmaceuticals NV for cutting-edge ESG-friendly pharmaceutical products.